Retrospective Review of a Rejuvenation
Program in the Management of
CancerVictor A. Marcial-Vega, MDwww.marcialvegamd.com
San Juan, Puerto RicoApril 2013
Presentation Overview
Patient Population Treatment Protocol Results Conclusions
Patient PopulationMay 1998 to February 2001
48 Cancer patients8 Patients Excluded from analysis
Evaluation of 40 patients
Patients excluded from analysis
7 patients less than 5 days of treatment
1 patient had chemotherapy
Total 8 patients
0
1
2
3
4
5
6
7
chem
o
<1 w
eek
Patient Population40 Cancer Patients33 Stage 4(2 had AIDS)
3 Unbiopsied patients
Patient Population40 Patients
1 Stage 1 Ewing’s Sarcoma
1 Stage 3 Squamous Neck
1 Stage 2 Breast1 Stage 1B Hodgkin’s
Patient Population Six patients failed conventional
therapy chemotherapy, radiation or surgery
All had progressive disease No patient was on concomitant
chemotherapy, surgery or radiation
Baseline StudiesSymptoms described by the patients
Present or Absent(1 or 2)
Treatment response(%)
Baseline StudiesCBC, chemistry panelTumor markers(CEA, serotonin)
CAT or MRI scans of tumor
Direct tumor measurements
Baseline StudiesHigh Resolution Blood Imaging indicates:
Free radical activityParasites, bacteria, fungipH
HRBI Setup
Treatment Program Initial Program 5 days a
week/ 3 weeks Optional-Maintenance
Program 5 days a week/1 week monthly
EnvironmentAromatherapyMusicRemoving shoes or surgical booties over shoes
House environment
Treatment Protocol Nutritional Supplementation Intravenous Vitamin C (+ or
- EDTA) Ozone/Hyperthermia
showers
Treatment Protocol
Hydromassage(daily 30 min)
Massage Therapy(1 hr 2x week)
Respiratory Biofeedback(30 min. daily)
Biofeedback
Treatment ProtocolSteambath/aromatherapy
Observation(Meditation) and Prayer
Daily monitoring by physician
Steambath
Treatment Protocol
Exercises to develop a practice of stillness, relaxation and focus
Use of books, videos, music,counseling
Intravenous Therapy
Vitamin C 20 grams Vitamins B1, B6(100 mg),
B12 (1000ug) Sterile water(250 cc) EDTA 2-6 cc(3g/21cc)
Intravenous Therapy
Three times a week 20 gram weekly increases
until 70 grams or tolerance is reached
Dose range 50-70 grams
Treatment Protocol All components of the
program promote being still and quiet.
All components of the program provide an opportunity for meditation and prayer
Ozone/Hyperthermia
Showers5 days a week1/2 hour treatments98-103 degrees Fahrenheit
ResultsAge Range 8-80 years Median 56 years
Median Follow-up 18 months
Analysis on 40 patients
Patient Subgroups
(A) 33 completed 3 weeks of protocol
(B) 5 completed 1 week (C) 2 had no ozone/hyperthermia
Survival 33/40 alive at time of
report(2002)(83%) Alive and well or recuperating (A) 19/33 = 57% (B) 2/5 = 40% (C) 0/2 = 0% Total 21/40= 53%
Initial Response More than 50%
response Within 3 weeks (A) 25/33= 76% (B) 3/5 = 60% (C) 1/2 = 50% Overall = 72%
01020304050607080
3 w
eeks
1 w
eek
no o
zone
percent
18 months results No tumor after
multiple recurrences 2/33
Complete Response 6/33
Partial 6/33 Total 14/33=42% 0
51015202530354045
no tu
m
CR PRto
tal
Percent
Symptoms Improvement in 80% first 2 weeks
Sustained at 5 months in 50%
RESULTSSymptoms always precede tumor response
Initial improvement seen first in sleep, energy level, emotional well being
ResultsAll patients that respond start looking and feeling better
Protocol is rejuvenating
Side Effects 2 patients- vitamin C
caused malaise. Resolved in 10 minutes after stopping infusion
1 patient- chills from infected catheter
1 patient- skin pimples
Prognosticators Not worrying A feeling of certainty this
program is for them Ambulatory and able to
take care of self Patients always get worse
when these factors are not present
PrognosticatorsTravel time less than 35 minutes 80% response
Travel time more than 35 minutes 20% response
PrognosticatorsThe addition of ozone/hyperthermia has improved our results from an initial response of 20% in stage 4 cancer to 79%
ConclusionsRejuvenation Program will yield an initial response rate of 79% in stage 4 cancer
18 month response is 36%
ConclusionsResponse needs to be measured with symptoms as well as tumor regression since these always precede physical signs of response
Conclusions Survival is 53% CR in 6/33 patients=18% 2/2 AIDS related cancers in
complete remission 1 CR Stage 3 lymphoma 1 CR recurrent T4 SCC RMT 1 CR Multiple Myeloma 1CR Endometrial CA Stage 4
Future DirectionsDevelop a physician network in the world that will use ozone/hyperthermia
Add the use of colonicsContinuing beyond 3 weeks
Future DirectionsStart managing stage 1 and 2 cancer patients with an integrated non-toxic program
Implement as part of anti-aging programs worldwide
Mind-Body-Spirit Counseling